These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26318388)

  • 1. Uric acid and xanthine oxidase in heart failure - Emerging data and therapeutic implications.
    Doehner W; Jankowska EA; Springer J; Lainscak M; Anker SD
    Int J Cardiol; 2016 Jun; 213():15-9. PubMed ID: 26318388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options.
    Doehner W; Landmesser U
    Semin Nephrol; 2011 Sep; 31(5):433-40. PubMed ID: 22000650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition.
    Harzand A; Tamariz L; Hare JM
    Congest Heart Fail; 2012; 18(3):179-82. PubMed ID: 22587748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure?
    Duan X; Ling F
    Med Hypotheses; 2008; 70(3):578-81. PubMed ID: 17689199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
    Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid, xanthine oxidase and heart failure: unresolved issues.
    Verdejo H; Alcaino H; Greig D; Garcia L; Pizarro M; Chiong M; Castro P; Lavandero S
    Eur J Heart Fail; 2008 Dec; 10(12):1271-2. PubMed ID: 19010082
    [No Abstract]   [Full Text] [Related]  

  • 7. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.
    Anker SD; Doehner W; Rauchhaus M; Sharma R; Francis D; Knosalla C; Davos CH; Cicoira M; Shamim W; Kemp M; Segal R; Osterziel KJ; Leyva F; Hetzer R; Ponikowski P; Coats AJ
    Circulation; 2003 Apr; 107(15):1991-7. PubMed ID: 12707250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricemia and the Risk of Heart Failure: Pathophysiology and Therapeutic Implications.
    Si K; Wei C; Xu L; Zhou Y; Lv W; Dong B; Wang Z; Huang Y; Wang Y; Chen Y
    Front Endocrinol (Lausanne); 2021; 12():770815. PubMed ID: 34867815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis.
    Kushiyama A; Nakatsu Y; Matsunaga Y; Yamamotoya T; Mori K; Ueda K; Inoue Y; Sakoda H; Fujishiro M; Ono H; Asano T
    Mediators Inflamm; 2016; 2016():8603164. PubMed ID: 28070145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia.
    Springer J; Tschirner A; Hartman K; Palus S; Wirth EK; Ruis SB; Möller N; von Haehling S; Argiles JM; Köhrle J; Adams V; Anker SD; Doehner W
    Int J Cancer; 2012 Nov; 131(9):2187-96. PubMed ID: 22336965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology.
    Hare JM; Johnson RJ
    Circulation; 2003 Apr; 107(15):1951-3. PubMed ID: 12707249
    [No Abstract]   [Full Text] [Related]  

  • 12. Uric acid in chronic heart failure: a marker of chronic inflammation.
    Leyva F; Anker SD; Godsland IF; Teixeira M; Hellewell PG; Kox WJ; Poole-Wilson PA; Coats AJ
    Eur Heart J; 1998 Dec; 19(12):1814-22. PubMed ID: 9886724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-based pharmacokinetic-pharmacodynamic modeling of salvianolic acid A effects on plasma xanthine oxidase activity and uric acid levels in acute myocardial infarction rats.
    Wang H; Li X; Zhang W; Liu Y; Wang S; Liu X; He H
    Xenobiotica; 2017 Mar; 47(3):208-216. PubMed ID: 27165094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.
    Bove M; Cicero AF; Veronesi M; Borghi C
    Vasc Health Risk Manag; 2017; 13():23-28. PubMed ID: 28223818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthine oxidase inhibition attenuates skeletal muscle signaling following acute exercise but does not impair mitochondrial adaptations to endurance training.
    Wadley GD; Nicolas MA; Hiam DS; McConell GK
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E853-62. PubMed ID: 23462817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopurinol, xanthine oxidase, and cardiac ischemia.
    Lee BE; Toledo AH; Anaya-Prado R; Roach RR; Toledo-Pereyra LH
    J Investig Med; 2009 Dec; 57(8):902-9. PubMed ID: 19794315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry.
    Baldasseroni S; Urso R; Maggioni AP; Orso F; Fabbri G; Marchionni N; Tavazzi L;
    Nutr Metab Cardiovasc Dis; 2012 May; 22(5):442-8. PubMed ID: 21193292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased xanthine oxidase-related ROS production and TRPV1 synthesis preceding DOMS post-eccentric exercise in rats.
    Retamoso LT; Silveira ME; Lima FD; Busanello GL; Bresciani G; Ribeiro LR; Chagas PM; Nogueira CW; Braga AC; Furian AF; Oliveira MS; Fighera MR; Royes LF
    Life Sci; 2016 May; 152():52-9. PubMed ID: 26987748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of allopurinol on striatal dopamine, ascorbate and uric acid during an acute morphine challenge: ex vivo and in vivo studies.
    Enrico P; Esposito G; Mura MA; Migheli R; Serra PA; Desole MS; Miele E; De Natale G; Miele M
    Pharmacol Res; 1997 Jun; 35(6):577-85. PubMed ID: 9356212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthine oxidase and uric acid as independent predictors of albuminuria in patients with diabetes mellitus type 2.
    Klisic A; Kocic G; Kavaric N; Jovanovic M; Stanisic V; Ninic A
    Clin Exp Med; 2018 May; 18(2):283-290. PubMed ID: 29214397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.